Literature DB >> 16267496

Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002.

.   

Abstract

Diabetes mellitus is the leading cause of end-stage renal disease (ESRD) (i.e., kidney failure requiring dialysis or transplantation) in the United States, accounting for 44% of new cases of treated ESRD in 2002. To examine trends in ESRD attributed to diabetes mellitus (ESRD-DM) in the United States, CDC analyzed 1990-2002 data from the United States Renal Data System (USRDS) and the National Health Interview Survey (NHIS). This report summarizes the findings of that analysis, which indicated that, although the number of new cases of ESRD-DM increased overall, the incidence of ESRD-DM among persons with diabetes is not increasing among blacks, Hispanics, men, and persons aged 65-74 years, and is declining among persons aged <65 years, women, and whites. Continued interventions to reduce the prevalence of risk factors for kidney disease and improve diabetes care are needed to sustain and improve these trends.

Entities:  

Mesh:

Year:  2005        PMID: 16267496

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  25 in total

1.  Geographic differences in the increasing ESRD rate have disappeared in Japan.

Authors:  Tamaki Wakamatsu-Yamanaka; Michio Fukuda; Ryo Sato; Takehiro Naito; Hiroyuki Togawa; Tatsuya Tomonari; Yoko Kato; Toshiyuki Miura; Masashi Mizuno; Tadashi Ichikawa; Sota Miyagi; Yuichi Shirasawa; Akinori Ito; Atsuhiro Yoshida; Genjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2011-06-03       Impact factor: 2.801

Review 2.  New potential agents in treating diabetic kidney disease: the fourth act.

Authors:  Mark E Williams
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Newly diagnosed diabetes mellitus as a risk factor for serious liver disease.

Authors:  Liane Porepa; Joel G Ray; Paula Sanchez-Romeu; Gillian L Booth
Journal:  CMAJ       Date:  2010-06-21       Impact factor: 8.262

4.  Secular trends in diabetes-related preventable hospitalizations in the United States, 1998-2006.

Authors:  Jing Wang; Kumiko Imai; Michael M Engelgau; Linda S Geiss; Christina Wen; Ping Zhang
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 17.152

5.  Trends in diabetes prevalence and diabetes-related complications in older Mexican Americans from 1993-1994 to 2004-2005.

Authors:  Holly A Beard; Majd AlGhatrif; Majd Al Ghatrif; Rafael Samper-Ternent; Kerstin Gerst; Kyriakos S Markides
Journal:  Diabetes Care       Date:  2009-09-15       Impact factor: 17.152

Review 6.  Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review.

Authors:  Sherita H Golden; Karen A Robinson; Ian Saldanha; Blair Anton; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2009-06       Impact factor: 5.958

Review 7.  Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy.

Authors:  R Simó; C Hernández
Journal:  Diabetologia       Date:  2008-04-11       Impact factor: 10.122

Review 8.  Sugar, sex, and TGF-β in diabetic nephropathy.

Authors:  Maggie K Diamond-Stanic; Young H You; Kumar Sharma
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

9.  Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline.

Authors:  Nilka Ríos Burrows; Yanfeng Li; Linda S Geiss
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

10.  Development of risk maps to minimize uranium exposures in the Navajo Churchrock mining district.

Authors:  Jamie L deLemos; Doug Brugge; Miranda Cajero; Mallery Downs; John L Durant; Christine M George; Sarah Henio-Adeky; Teddy Nez; Thomas Manning; Tommy Rock; Bess Seschillie; Chris Shuey; Johnnye Lewis
Journal:  Environ Health       Date:  2009-07-09       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.